Date:10/6/2010

support. Inter/Media's proprietary and precedent-setting lead/sales tracking system AccuTrak® provides clients with statistical data on the relationship between advertising spend and consumer response. The company is comprised of ten business units--Inter/Media Advertising® (strategy, planning and research), Inter/Media Time Buying Corp®  (offline media execution), Inter/Media Interactive (online planning, buying and creative), Mediapoint Network® (Performance-based advertising), Inter/Image Productions®, Inter/Post Productions® Editorial, InterQuantum, LLC (retail brokering, marketing consulting), InfoTech Development™ (advertising and media metrics technology), Inter/Media Properties™ and Bellatrix Media™. Bellatrix Media includes the American Target Network, which features unwired networks comprised of cable, broadcast TV, and radio media.  For more information, go to http://www.Intermedia-Advertising.com.

EDITORS NOTE: 300 dpi downloadable photos are available at www.intermedia-advertising.com/media.html

'/>"/>

SOURCE Inter/Media Advertising Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients
2. New York Plastic Surgery News: Medical Tourists Beware of Drug-Resistant Superbug NDM-1
3. BCM-95 Demonstrates Superior Anti-Inflammatory Effects
4. New Super Exam 50® LED from Burton Medical Provides the Most Positionable, High Intensity Diagnostic Light Available
5. Burton Medical Offers Affordable and Superior Illumination With New LE-35
6. Sacramento County Board of Supervisors Declare Voices of Meningitis Week
7. New Supercomputer Connection Speeds Genetic Research
8. Newly Published Data Demonstrate ASP EVOTECH® ECR Provides Cleaning That is Superior to Manual Cleaning of Flexible Endoscopes
9. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year
10. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52 Weeks
11. The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes